nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofazimine—ABCB11—Vincristine—sarcoma	0.261	0.299	CbGbCtD
Clofazimine—ABCB11—Doxorubicin—sarcoma	0.163	0.187	CbGbCtD
Clofazimine—CYP3A4—Thiotepa—sarcoma	0.0906	0.104	CbGbCtD
Clofazimine—ABCB1—Dactinomycin—sarcoma	0.0726	0.0832	CbGbCtD
Clofazimine—ABCB1—Mitoxantrone—sarcoma	0.065	0.0745	CbGbCtD
Clofazimine—ABCB1—Vincristine—sarcoma	0.0447	0.0512	CbGbCtD
Clofazimine—ABCB1—Etoposide—sarcoma	0.041	0.047	CbGbCtD
Clofazimine—CYP3A4—Mitoxantrone—sarcoma	0.0389	0.0446	CbGbCtD
Clofazimine—ABCB1—Doxorubicin—sarcoma	0.0279	0.032	CbGbCtD
Clofazimine—CYP3A4—Vincristine—sarcoma	0.0268	0.0307	CbGbCtD
Clofazimine—CYP3A4—Etoposide—sarcoma	0.0246	0.0281	CbGbCtD
Clofazimine—CYP3A4—Doxorubicin—sarcoma	0.0167	0.0192	CbGbCtD
Clofazimine—Enteritis—Thiotepa—sarcoma	0.0055	0.0432	CcSEcCtD
Clofazimine—Enteritis—Mitoxantrone—sarcoma	0.00475	0.0373	CcSEcCtD
Clofazimine—Epigastric pain—Mitoxantrone—sarcoma	0.00336	0.0264	CcSEcCtD
Clofazimine—Embolism—Thiotepa—sarcoma	0.00293	0.023	CcSEcCtD
Clofazimine—Intestinal obstruction—Thiotepa—sarcoma	0.00275	0.0216	CcSEcCtD
Clofazimine—Hepatomegaly—Thiotepa—sarcoma	0.00265	0.0208	CcSEcCtD
Clofazimine—Hepatomegaly—Dactinomycin—sarcoma	0.00263	0.0207	CcSEcCtD
Clofazimine—Intestinal obstruction—Vincristine—sarcoma	0.00244	0.0192	CcSEcCtD
Clofazimine—Thromboembolism—Epirubicin—sarcoma	0.00238	0.0187	CcSEcCtD
Clofazimine—Thromboembolism—Doxorubicin—sarcoma	0.0022	0.0173	CcSEcCtD
Clofazimine—Skin discolouration—Thiotepa—sarcoma	0.00208	0.0163	CcSEcCtD
Clofazimine—Cystitis noninfective—Thiotepa—sarcoma	0.00183	0.0144	CcSEcCtD
Clofazimine—Cystitis—Thiotepa—sarcoma	0.00181	0.0142	CcSEcCtD
Clofazimine—Bone pain—Vincristine—sarcoma	0.00174	0.0137	CcSEcCtD
Clofazimine—Bladder pain—Thiotepa—sarcoma	0.0017	0.0133	CcSEcCtD
Clofazimine—Bone pain—Mitoxantrone—sarcoma	0.00169	0.0133	CcSEcCtD
Clofazimine—Embolism venous—Epirubicin—sarcoma	0.0015	0.0118	CcSEcCtD
Clofazimine—Skin discolouration—Etoposide—sarcoma	0.00149	0.0117	CcSEcCtD
Clofazimine—Embolism venous—Doxorubicin—sarcoma	0.00139	0.0109	CcSEcCtD
Clofazimine—Embolism—Epirubicin—sarcoma	0.00118	0.00925	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Mitoxantrone—sarcoma	0.00118	0.00925	CcSEcCtD
Clofazimine—Embolism—Doxorubicin—sarcoma	0.00109	0.00856	CcSEcCtD
Clofazimine—Neuralgia—Epirubicin—sarcoma	0.00109	0.00855	CcSEcCtD
Clofazimine—Abdominal pain upper—Mitoxantrone—sarcoma	0.00108	0.00845	CcSEcCtD
Clofazimine—Hypokalaemia—Mitoxantrone—sarcoma	0.00107	0.00842	CcSEcCtD
Clofazimine—Hepatomegaly—Epirubicin—sarcoma	0.00107	0.00839	CcSEcCtD
Clofazimine—Hyperglycaemia—Thiotepa—sarcoma	0.00106	0.00835	CcSEcCtD
Clofazimine—Jaundice—Thiotepa—sarcoma	0.00102	0.00804	CcSEcCtD
Clofazimine—Neuralgia—Doxorubicin—sarcoma	0.00101	0.00791	CcSEcCtD
Clofazimine—Hepatomegaly—Doxorubicin—sarcoma	0.000988	0.00777	CcSEcCtD
Clofazimine—Photosensitivity reaction—Vincristine—sarcoma	0.000954	0.00749	CcSEcCtD
Clofazimine—Weight decreased—Vincristine—sarcoma	0.000945	0.00743	CcSEcCtD
Clofazimine—Hepatitis—Dactinomycin—sarcoma	0.000936	0.00735	CcSEcCtD
Clofazimine—Depression—Vincristine—sarcoma	0.000929	0.0073	CcSEcCtD
Clofazimine—Weight decreased—Mitoxantrone—sarcoma	0.000921	0.00723	CcSEcCtD
Clofazimine—Hyperglycaemia—Mitoxantrone—sarcoma	0.000918	0.00721	CcSEcCtD
Clofazimine—Drowsiness—Mitoxantrone—sarcoma	0.000907	0.00713	CcSEcCtD
Clofazimine—Jaundice—Mitoxantrone—sarcoma	0.000884	0.00695	CcSEcCtD
Clofazimine—Skin discolouration—Epirubicin—sarcoma	0.000837	0.00658	CcSEcCtD
Clofazimine—Hepatitis—Mitoxantrone—sarcoma	0.000814	0.0064	CcSEcCtD
Clofazimine—Bone pain—Epirubicin—sarcoma	0.000789	0.0062	CcSEcCtD
Clofazimine—Skin discolouration—Doxorubicin—sarcoma	0.000775	0.00609	CcSEcCtD
Clofazimine—Anaemia—Thiotepa—sarcoma	0.000759	0.00596	CcSEcCtD
Clofazimine—Anaemia—Dactinomycin—sarcoma	0.000753	0.00592	CcSEcCtD
Clofazimine—Cystitis noninfective—Epirubicin—sarcoma	0.000739	0.0058	CcSEcCtD
Clofazimine—Jaundice—Etoposide—sarcoma	0.000736	0.00578	CcSEcCtD
Clofazimine—Bone pain—Doxorubicin—sarcoma	0.00073	0.00574	CcSEcCtD
Clofazimine—Cystitis—Epirubicin—sarcoma	0.00073	0.00574	CcSEcCtD
Clofazimine—Bladder pain—Epirubicin—sarcoma	0.000684	0.00537	CcSEcCtD
Clofazimine—Cystitis noninfective—Doxorubicin—sarcoma	0.000683	0.00537	CcSEcCtD
Clofazimine—Cystitis—Doxorubicin—sarcoma	0.000676	0.00531	CcSEcCtD
Clofazimine—Anaemia—Vincristine—sarcoma	0.000673	0.00529	CcSEcCtD
Clofazimine—Oedema—Dactinomycin—sarcoma	0.000665	0.00522	CcSEcCtD
Clofazimine—Anaemia—Mitoxantrone—sarcoma	0.000655	0.00515	CcSEcCtD
Clofazimine—Lymphadenopathy—Epirubicin—sarcoma	0.000643	0.00505	CcSEcCtD
Clofazimine—Anorexia—Thiotepa—sarcoma	0.000639	0.00502	CcSEcCtD
Clofazimine—Anorexia—Dactinomycin—sarcoma	0.000634	0.00498	CcSEcCtD
Clofazimine—Bladder pain—Doxorubicin—sarcoma	0.000633	0.00497	CcSEcCtD
Clofazimine—Somnolence—Thiotepa—sarcoma	0.000596	0.00468	CcSEcCtD
Clofazimine—Lymphadenopathy—Doxorubicin—sarcoma	0.000595	0.00468	CcSEcCtD
Clofazimine—Oedema—Vincristine—sarcoma	0.000594	0.00467	CcSEcCtD
Clofazimine—Decreased appetite—Thiotepa—sarcoma	0.000582	0.00458	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Epirubicin—sarcoma	0.000582	0.00457	CcSEcCtD
Clofazimine—Oedema—Mitoxantrone—sarcoma	0.000579	0.00455	CcSEcCtD
Clofazimine—Decreased appetite—Dactinomycin—sarcoma	0.000578	0.00454	CcSEcCtD
Clofazimine—Fatigue—Thiotepa—sarcoma	0.000578	0.00454	CcSEcCtD
Clofazimine—Fatigue—Dactinomycin—sarcoma	0.000573	0.0045	CcSEcCtD
Clofazimine—Constipation—Thiotepa—sarcoma	0.000573	0.0045	CcSEcCtD
Clofazimine—Anorexia—Vincristine—sarcoma	0.000566	0.00445	CcSEcCtD
Clofazimine—Anorexia—Mitoxantrone—sarcoma	0.000552	0.00433	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.000549	0.00431	CcSEcCtD
Clofazimine—Anaemia—Etoposide—sarcoma	0.000545	0.00428	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Doxorubicin—sarcoma	0.000538	0.00423	CcSEcCtD
Clofazimine—Body temperature increased—Thiotepa—sarcoma	0.00053	0.00416	CcSEcCtD
Clofazimine—Body temperature increased—Dactinomycin—sarcoma	0.000526	0.00413	CcSEcCtD
Clofazimine—Decreased appetite—Vincristine—sarcoma	0.000516	0.00406	CcSEcCtD
Clofazimine—Somnolence—Mitoxantrone—sarcoma	0.000514	0.00404	CcSEcCtD
Clofazimine—Fatigue—Vincristine—sarcoma	0.000512	0.00402	CcSEcCtD
Clofazimine—Constipation—Vincristine—sarcoma	0.000508	0.00399	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000508	0.00399	CcSEcCtD
Clofazimine—Decreased appetite—Mitoxantrone—sarcoma	0.000503	0.00395	CcSEcCtD
Clofazimine—Abdominal pain upper—Epirubicin—sarcoma	0.000501	0.00394	CcSEcCtD
Clofazimine—Hypokalaemia—Epirubicin—sarcoma	0.0005	0.00392	CcSEcCtD
Clofazimine—Fatigue—Mitoxantrone—sarcoma	0.000499	0.00392	CcSEcCtD
Clofazimine—Constipation—Mitoxantrone—sarcoma	0.000495	0.00389	CcSEcCtD
Clofazimine—Asthenia—Thiotepa—sarcoma	0.000481	0.00378	CcSEcCtD
Clofazimine—Asthenia—Dactinomycin—sarcoma	0.000477	0.00375	CcSEcCtD
Clofazimine—Pruritus—Thiotepa—sarcoma	0.000474	0.00372	CcSEcCtD
Clofazimine—Eosinophilia—Epirubicin—sarcoma	0.00047	0.00369	CcSEcCtD
Clofazimine—Body temperature increased—Vincristine—sarcoma	0.00047	0.00369	CcSEcCtD
Clofazimine—Abdominal pain upper—Doxorubicin—sarcoma	0.000464	0.00364	CcSEcCtD
Clofazimine—Hypokalaemia—Doxorubicin—sarcoma	0.000462	0.00363	CcSEcCtD
Clofazimine—Anorexia—Etoposide—sarcoma	0.000459	0.0036	CcSEcCtD
Clofazimine—Diarrhoea—Thiotepa—sarcoma	0.000458	0.0036	CcSEcCtD
Clofazimine—Body temperature increased—Mitoxantrone—sarcoma	0.000457	0.00359	CcSEcCtD
Clofazimine—Diarrhoea—Dactinomycin—sarcoma	0.000455	0.00357	CcSEcCtD
Clofazimine—Dizziness—Thiotepa—sarcoma	0.000443	0.00348	CcSEcCtD
Clofazimine—Eosinophilia—Doxorubicin—sarcoma	0.000435	0.00341	CcSEcCtD
Clofazimine—Photosensitivity reaction—Epirubicin—sarcoma	0.000433	0.0034	CcSEcCtD
Clofazimine—Weight decreased—Epirubicin—sarcoma	0.000429	0.00337	CcSEcCtD
Clofazimine—Hyperglycaemia—Epirubicin—sarcoma	0.000428	0.00336	CcSEcCtD
Clofazimine—Somnolence—Etoposide—sarcoma	0.000428	0.00336	CcSEcCtD
Clofazimine—Asthenia—Vincristine—sarcoma	0.000426	0.00335	CcSEcCtD
Clofazimine—Vomiting—Thiotepa—sarcoma	0.000426	0.00335	CcSEcCtD
Clofazimine—Drowsiness—Epirubicin—sarcoma	0.000423	0.00332	CcSEcCtD
Clofazimine—Vomiting—Dactinomycin—sarcoma	0.000423	0.00332	CcSEcCtD
Clofazimine—Rash—Thiotepa—sarcoma	0.000422	0.00332	CcSEcCtD
Clofazimine—Dermatitis—Thiotepa—sarcoma	0.000422	0.00332	CcSEcCtD
Clofazimine—Headache—Thiotepa—sarcoma	0.00042	0.0033	CcSEcCtD
Clofazimine—Rash—Dactinomycin—sarcoma	0.000419	0.00329	CcSEcCtD
Clofazimine—Decreased appetite—Etoposide—sarcoma	0.000418	0.00329	CcSEcCtD
Clofazimine—Asthenia—Mitoxantrone—sarcoma	0.000415	0.00326	CcSEcCtD
Clofazimine—Fatigue—Etoposide—sarcoma	0.000415	0.00326	CcSEcCtD
Clofazimine—Jaundice—Epirubicin—sarcoma	0.000412	0.00324	CcSEcCtD
Clofazimine—Constipation—Etoposide—sarcoma	0.000412	0.00323	CcSEcCtD
Clofazimine—Diarrhoea—Vincristine—sarcoma	0.000406	0.00319	CcSEcCtD
Clofazimine—Photosensitivity reaction—Doxorubicin—sarcoma	0.000401	0.00315	CcSEcCtD
Clofazimine—Nausea—Thiotepa—sarcoma	0.000398	0.00313	CcSEcCtD
Clofazimine—Weight decreased—Doxorubicin—sarcoma	0.000397	0.00312	CcSEcCtD
Clofazimine—Hyperglycaemia—Doxorubicin—sarcoma	0.000396	0.00311	CcSEcCtD
Clofazimine—Diarrhoea—Mitoxantrone—sarcoma	0.000396	0.00311	CcSEcCtD
Clofazimine—Nausea—Dactinomycin—sarcoma	0.000395	0.0031	CcSEcCtD
Clofazimine—Dizziness—Vincristine—sarcoma	0.000393	0.00309	CcSEcCtD
Clofazimine—Drowsiness—Doxorubicin—sarcoma	0.000391	0.00307	CcSEcCtD
Clofazimine—Jaundice—Doxorubicin—sarcoma	0.000381	0.003	CcSEcCtD
Clofazimine—Body temperature increased—Etoposide—sarcoma	0.00038	0.00299	CcSEcCtD
Clofazimine—Hepatitis—Epirubicin—sarcoma	0.00038	0.00298	CcSEcCtD
Clofazimine—Vomiting—Vincristine—sarcoma	0.000378	0.00297	CcSEcCtD
Clofazimine—Rash—Vincristine—sarcoma	0.000375	0.00294	CcSEcCtD
Clofazimine—Dermatitis—Vincristine—sarcoma	0.000374	0.00294	CcSEcCtD
Clofazimine—Headache—Vincristine—sarcoma	0.000372	0.00292	CcSEcCtD
Clofazimine—Vomiting—Mitoxantrone—sarcoma	0.000368	0.00289	CcSEcCtD
Clofazimine—Visual impairment—Epirubicin—sarcoma	0.000366	0.00287	CcSEcCtD
Clofazimine—Rash—Mitoxantrone—sarcoma	0.000365	0.00287	CcSEcCtD
Clofazimine—Dermatitis—Mitoxantrone—sarcoma	0.000364	0.00286	CcSEcCtD
Clofazimine—Headache—Mitoxantrone—sarcoma	0.000362	0.00285	CcSEcCtD
Clofazimine—Nausea—Vincristine—sarcoma	0.000353	0.00277	CcSEcCtD
Clofazimine—Hepatitis—Doxorubicin—sarcoma	0.000351	0.00276	CcSEcCtD
Clofazimine—Asthenia—Etoposide—sarcoma	0.000345	0.00271	CcSEcCtD
Clofazimine—Nausea—Mitoxantrone—sarcoma	0.000344	0.0027	CcSEcCtD
Clofazimine—Pruritus—Etoposide—sarcoma	0.00034	0.00267	CcSEcCtD
Clofazimine—Visual impairment—Doxorubicin—sarcoma	0.000339	0.00266	CcSEcCtD
Clofazimine—Diarrhoea—Etoposide—sarcoma	0.000329	0.00259	CcSEcCtD
Clofazimine—Dizziness—Etoposide—sarcoma	0.000318	0.0025	CcSEcCtD
Clofazimine—Vomiting—Etoposide—sarcoma	0.000306	0.0024	CcSEcCtD
Clofazimine—Anaemia—Epirubicin—sarcoma	0.000306	0.0024	CcSEcCtD
Clofazimine—Rash—Etoposide—sarcoma	0.000303	0.00238	CcSEcCtD
Clofazimine—Dermatitis—Etoposide—sarcoma	0.000303	0.00238	CcSEcCtD
Clofazimine—Headache—Etoposide—sarcoma	0.000301	0.00237	CcSEcCtD
Clofazimine—Nausea—Etoposide—sarcoma	0.000286	0.00225	CcSEcCtD
Clofazimine—Anaemia—Doxorubicin—sarcoma	0.000283	0.00222	CcSEcCtD
Clofazimine—Oedema—Epirubicin—sarcoma	0.00027	0.00212	CcSEcCtD
Clofazimine—Anorexia—Epirubicin—sarcoma	0.000257	0.00202	CcSEcCtD
Clofazimine—Oedema—Doxorubicin—sarcoma	0.00025	0.00196	CcSEcCtD
Clofazimine—Somnolence—Epirubicin—sarcoma	0.00024	0.00188	CcSEcCtD
Clofazimine—Anorexia—Doxorubicin—sarcoma	0.000238	0.00187	CcSEcCtD
Clofazimine—Decreased appetite—Epirubicin—sarcoma	0.000235	0.00184	CcSEcCtD
Clofazimine—Fatigue—Epirubicin—sarcoma	0.000233	0.00183	CcSEcCtD
Clofazimine—Constipation—Epirubicin—sarcoma	0.000231	0.00181	CcSEcCtD
Clofazimine—Somnolence—Doxorubicin—sarcoma	0.000222	0.00174	CcSEcCtD
Clofazimine—Decreased appetite—Doxorubicin—sarcoma	0.000217	0.0017	CcSEcCtD
Clofazimine—Fatigue—Doxorubicin—sarcoma	0.000215	0.00169	CcSEcCtD
Clofazimine—Constipation—Doxorubicin—sarcoma	0.000213	0.00168	CcSEcCtD
Clofazimine—Body temperature increased—Epirubicin—sarcoma	0.000213	0.00168	CcSEcCtD
Clofazimine—Body temperature increased—Doxorubicin—sarcoma	0.000197	0.00155	CcSEcCtD
Clofazimine—Asthenia—Epirubicin—sarcoma	0.000194	0.00152	CcSEcCtD
Clofazimine—Pruritus—Epirubicin—sarcoma	0.000191	0.0015	CcSEcCtD
Clofazimine—Diarrhoea—Epirubicin—sarcoma	0.000185	0.00145	CcSEcCtD
Clofazimine—Asthenia—Doxorubicin—sarcoma	0.000179	0.00141	CcSEcCtD
Clofazimine—Dizziness—Epirubicin—sarcoma	0.000178	0.0014	CcSEcCtD
Clofazimine—Pruritus—Doxorubicin—sarcoma	0.000177	0.00139	CcSEcCtD
Clofazimine—Vomiting—Epirubicin—sarcoma	0.000172	0.00135	CcSEcCtD
Clofazimine—Diarrhoea—Doxorubicin—sarcoma	0.000171	0.00134	CcSEcCtD
Clofazimine—Rash—Epirubicin—sarcoma	0.00017	0.00134	CcSEcCtD
Clofazimine—Dermatitis—Epirubicin—sarcoma	0.00017	0.00134	CcSEcCtD
Clofazimine—Headache—Epirubicin—sarcoma	0.000169	0.00133	CcSEcCtD
Clofazimine—Dizziness—Doxorubicin—sarcoma	0.000165	0.0013	CcSEcCtD
Clofazimine—Nausea—Epirubicin—sarcoma	0.00016	0.00126	CcSEcCtD
Clofazimine—Vomiting—Doxorubicin—sarcoma	0.000159	0.00125	CcSEcCtD
Clofazimine—Rash—Doxorubicin—sarcoma	0.000157	0.00124	CcSEcCtD
Clofazimine—Dermatitis—Doxorubicin—sarcoma	0.000157	0.00124	CcSEcCtD
Clofazimine—Headache—Doxorubicin—sarcoma	0.000156	0.00123	CcSEcCtD
Clofazimine—Nausea—Doxorubicin—sarcoma	0.000148	0.00116	CcSEcCtD
